U.S. Stock News

NasdaqGM:NAMS
NasdaqGM:NAMSBiotechs

NewAmsterdam Pharma (NAMS) Earnings Losses Raise The Question Of Whether The Stock Is A Bargain

NewAmsterdam Pharma earnings jolt investor focus NewAmsterdam Pharma (NasdaqGM:NAMS) moved into the spotlight after its latest earnings report showed second quarter sales of US$3.7 million and a net loss of US$64.14 million, sharpening attention on its financial trajectory. See our latest analysis for NewAmsterdam Pharma. The recent earnings report landed against a weak share price backdrop for NewAmsterdam Pharma, with a 30 day share price return of down 15.63% and a year to date share price...
NYSE:MRP
NYSE:MRPSpecialized REITs

Millrose Properties (MRP) Stock Looks Reasonable Despite Its 6% One Year Gain

Millrose Properties stock has returned 5.7% over the past year, yet the broader valuation checks currently lean on the cheap side. This raises the question of whether the recent gains still leave room for further upside in the share price. A 5.7% one year return suggests Millrose Properties has moved up, but not in a way that clearly prices in a stretched valuation. Millrose's commitment to provide up to US$1.25b in capital support for Dream Finders Homes' acquisition plans can support...
NasdaqGS:SYNA
NasdaqGS:SYNASemiconductor

Did Surging Losses and Buybacks Just Shift Synaptics' (SYNA) Core IoT and Edge AI Narrative?

In August 2026, Synaptics reported fourth-quarter sales of US$308.0 million and full-year sales of US$1.20 billion, alongside a very large jump in net loss to US$447.4 million for the quarter and US$490.8 million for the year. At the same time, the company completed a share repurchase of 1,402,619 shares for US$99.94 million, highlighting an ongoing capital return program despite the widened losses. We’ll now examine how Synaptics’ sharply higher losses, despite revenue growth, could reshape...
NYSE:RLX
NYSE:RLXTobacco

RLX Technology (RLX) Stock Dropped, So What Is Driving Attention Now?

RLX Technology (RLX) is in focus after its Q2 2026 report, which combined 14.8% year over year revenue growth, an earnings miss versus expectations, and confirmation of a Western European acquisition and product expansion beyond e-vapor. See our latest analysis for RLX Technology. Despite the Q2 headlines, RLX Technology’s 1-day share price return declined 3%, with the 30-day share price return down 3.48% and the year to date share price return down 16.38%. The 3-year total shareholder return...
NasdaqGS:VCTR
NasdaqGS:VCTRCapital Markets

Victory Capital Holdings (VCTR) Is Up 9.3% After Strong Q2, Dividend Payout And Buybacks

In early August 2026, Victory Capital Holdings reported second-quarter results showing higher revenue of US$435.36 million and net income of US$139.4 million compared with the prior year, while its board maintained a regular quarterly cash dividend of US$0.50 per share and the company completed a significant share buyback tranche. Management also emphasized that the balance sheet and free cash flow support simultaneous reinvestment and shareholder payouts, with acquisition-led expansion...
NasdaqGS:ARQT
NasdaqGS:ARQTBiotechs

Should Arcutis Biotherapeutics’ (ARQT) Strong Q2 and Higher 2026 Sales Outlook Prompt Investor Action?

Arcutis Biotherapeutics recently reported that its chief commercial officer L. Todd Edwards resigned in August to pursue another opportunity, while second-quarter 2026 results showed revenue of US$129.86 million and net income of US$15.01 million, and management raised full-year 2026 net product sales guidance to US$525 million–US$540 million. Alongside the leadership change and stronger earnings, the higher sales outlook highlights how Arcutis’s commercial execution is tracking ahead of its...
NYSE:DAN
NYSE:DANAuto Components

Dana (DAN) Stock Looks Cheap On Sales While Its 3 Year Return Looks Strong

Dana stock has posted strong gains over the past few years, yet the current checks still frame it as undervalued on several measures. The recent share price strength now sits alongside a high value score that suggests the broader valuation picture still leans cheap rather than stretched. Over the past 3 years, Dana has delivered a total return of about 107.5%, which puts recent pricing in the context of a multi year rally rather than a short term swing. Future revenue and margin progress may...
NasdaqGS:CLBK
NasdaqGS:CLBKBanks

Is Columbia Financial (CLBK) Expensive After Higher Earnings Forecasts And A Strong Share Price Run?

Recent revisions to earnings forecasts have put Columbia Financial (CLBK) on investors’ radar. Analysts have aligned around higher expectations for the current quarter and full year, sparking fresh interest in the stock. See our latest analysis for Columbia Financial. Columbia Financial’s recent 1-day share price return of 0.68% extends a strong run, with a 30-day share price return of 17.90% and a year to date share price return of 68.21%. The 1-year total shareholder return of 79.20% points...
NYSE:NE
NYSE:NEEnergy Services

Noble (NE) Stock Looks About Right At Today’s Price

Noble stock has delivered very strong returns over the past five years, yet on current checks it does not screen as a clear bargain and instead looks closer to fairly valued. After such a run, investors are weighing whether recent price strength leaves limited room for error or still offers enough support for holding on. Noble has returned 145.4% over the last 5 years, which puts extra focus on whether the current share price already reflects much of the company’s progress. Future valuation...
NasdaqGS:AOSL
NasdaqGS:AOSLSemiconductor

Alpha and Omega Semiconductor (AOSL) Stock May Be Undervalued Despite Q4 Loss Preview

Alpha and Omega Semiconductor stock has climbed 48.9% year to date, yet its latest valuation checks and recent share price pullback raise questions about how much upside is realistically left. The 48.9% gain so far this year suggests investors have been willing to pay up for Alpha and Omega Semiconductor, which puts more focus on whether current expectations can be supported. Upcoming results, including the market’s focus on gross margins, demand across end markets and inventory levels, may...
NasdaqGS:NMRK
NasdaqGS:NMRKReal Estate

Newmark Group (NMRK) Plans A CEO Change, Is The Stock Still A Bargain?

Newmark Group (NMRK) has drawn fresh investor attention after announcing that long serving Chief Executive Officer Barry Gosin will step down on December 31, 2026, following decades in the role. See our latest analysis for Newmark Group. The CEO transition news comes after a mixed period for Newmark Group's stock, with the share price at US$15.25 and a share price return that is down 10.14% year to date but supported by a 3 year total shareholder return of 128.50%, which suggests that long...
NasdaqCM:AMPG
NasdaqCM:AMPGElectronic

AmpliTech Group (AMPG) Could Be 87% Undervalued As Q2 2026 Earnings Reset Sentiment

Why AmpliTech Group Stock Is Back In Focus After Q2 2026 Earnings AmpliTech Group (AMPG) is drawing fresh attention after its Q2 2026 earnings report showed lower sales and a wider net loss for both the quarter and the first half of the year. The company reported Q2 sales of US$8.07 million compared with US$11.03 million a year earlier, with net loss widening to US$3.09 million. For the first six months of 2026, sales were US$13.42 million versus US$14.63 million, while net loss increased to...
NYSE:SWX
NYSE:SWXGas Utilities

Southwest Gas Holdings (SWX) Returned To Profit, Is It Still A Bargain?

Southwest Gas Holdings (SWX) recently reported second quarter 2026 earnings that shifted from a net loss to a net profit year over year, while also reaffirming full year earnings guidance for continuing operations. See our latest analysis for Southwest Gas Holdings. The reaffirmed 2026 earnings guidance and move back to profitability appear to sit alongside strengthening market confidence in Southwest Gas Holdings, with a year to date share price return of 15.53% and a 3 year total...
NasdaqGM:MDWD
NasdaqGM:MDWDPharmaceuticals

MediWound (MDWD) Stock Faces Cash Burn As Revenue Slips

MediWound walked into this print as a high-growth, high-expectation biotech, yet the stock barely moved, up just 0.04% on the day and still down over the past week, month and quarter. That flat reaction hides a more complicated headline. Q2 revenue came in at US$3.1m, while the company booked a net loss of US$7.4m, or US$0.57 per share, as spending on EscharEx Phase III work and NexoBrid scale-up pulled harder on the income statement. Is MediWound trading at a justifiable premium P/S of...
NasdaqCM:OTLK
NasdaqCM:OTLKBiotechs

Outlook Therapeutics (OTLK) Stock Looks Fully Valued While Book Value Stays Unclear

Outlook Therapeutics stock has had a very difficult five years, with the share price down about 98.3%, and the latest valuation checks currently do not flag the stock as a clear bargain despite this steep decline. Over the past five years, Outlook Therapeutics has declined around 98.3%, which means long term shareholders have seen most of their equity value eroded. The recent approval and planned U.S. launch of LYTENAVA, supported by a US$55 million equity offering, can help fund growth but...
NYSE:TDC
NYSE:TDCSoftware

Will Stronger EPS Guidance and New AWS AI Tools Change Teradata's (TDC) Narrative

In August 2026, Teradata Corporation reported past second-quarter 2026 results showing revenue of US$410 million and net income of US$46 million, alongside updated guidance calling for relatively flat full-year revenue but higher GAAP diluted EPS of US$4.43 to US$4.51. At the same time, Teradata pushed further into AI-enabled analytics with the launch of its Data Analyst Agent on Amazon Web Services Marketplace and added experienced technology executive Bernd Leukert to its expanded Board,...
NYSE:ARCO
NYSE:ARCOHospitality

Arcos Dorados (ARCO) Stock Slips As Record Margins Challenge Macro Fears

Arcos Dorados Holdings stock slipped about 3% to US$7.91 after the Q2 print, even though the quarter landed with record revenue of roughly US$1.3b and the highest adjusted earnings before interest, tax, depreciation and amortization in its history. You are watching a market that seems more focused on recent share price drift than on what was just put on the income statement. The real story in this earnings release sits in margins and cash generation. Profitability improved and adjusted free...
NasdaqGS:UFCS
NasdaqGS:UFCSInsurance

Stronger Profit Without Buybacks Might Change The Case For Investing In United Fire Group (UFCS)

In the past quarter, United Fire Group, Inc. reported second-quarter 2026 revenue of US$383.73 million and net income of US$33.37 million, with diluted EPS from continuing operations of US$1.29, while not repurchasing any shares between April 1 and June 30 under its long-running buyback program. These results capped a first half where both revenue and net income rose compared with the prior year, suggesting that improved operating performance rather than share repurchases has been the main...
NYSE:RBC
NYSE:RBCMachinery

RBC Bearings (RBC) Stock Looks Pricey As Its 156% Run Continues

RBC Bearings stock has delivered very strong share price gains over the past three years, yet both its Discounted Cash Flow (DCF) intrinsic value estimate and market multiples currently point to the shares trading at a premium. RBC Bearings has returned 155.8% over the past three years, which puts extra focus on whether the current price still leaves much room for further value. The recent acquisition of PSC Couplings can support future cash flow growth, while any difficulty integrating new...
NYSE:A
NYSE:ALife Sciences

Agilent (A) Stock Looks Below Fair Value But Above Fair Value On Earnings

Agilent Technologies stock has delivered a 27.4% return over the past three years, while its valuation checks now show a split picture where the Discounted Cash Flow (DCF) intrinsic value points to upside and the market multiples look less generous. Over the past three years, Agilent Technologies returned 27.4%, which puts recent gains and today’s valuation in sharper focus for long term holders. The expanded EU approval for Agilent Technologies’ PD-L1 diagnostic test can support...
NYSE:DFIN
NYSE:DFINCapital Markets

How Donnelley Financial’s Shift Toward Subscription Software Could Impact Donnelley Financial Solutions (DFIN) Investors

Donnelley Financial Solutions recently advanced its transition toward a subscription-based model, emphasizing expanding software revenue streams to deepen client relationships and increase recurring income, a shift that has already occurred by today. This move highlights how Donnelley Financial is reshaping its business mix away from traditional services toward software-centric offerings, while accepting meaningful execution risk during the transformation. We’ll now examine how Donnelley...
NYSE:AUB
NYSE:AUBBanks

Atlantic Union Bankshares (AUB), Why Is The Market Taking A Closer Look?

Atlantic Union Bankshares (AUB) has drawn investor interest after its recent share price performance, with the stock last closing at $42.88. This move has put a spotlight on how its banking business supports this valuation. See our latest analysis for Atlantic Union Bankshares. Looking beyond the latest move to $42.88, Atlantic Union Bankshares has shown building momentum, with a 90-day share price return of 18.03% and a 1-year total shareholder return of 32.72% supported by a 3-year total...
NasdaqGS:HTFL
NasdaqGS:HTFLHealthcare Services

HeartFlow (HTFL) Stock Rally Meets Widening Losses And Premium Valuation

HeartFlow stock exploded 35.7% higher to US$42.08 in the first full session after earnings. That is an emotional move for a company that still reports losses. The spark was not a one off headline. Q2 revenue reached US$64.1m and management lifted full year guidance to a range of US$246m to US$250m, which highlights the growth story investors have been paying up for. The key question now is whether this surge simply reflects the stronger fundamentals on display or stretches an already rich...
NYSE:FBP
NYSE:FBPBanks

Does First BanCorp’s (FBP) Richer Dividend Signal a New Balance Between Income and Growth?

Recently, First BanCorp announced that its annualized dividend has risen by 11.1%, lifting its dividend yield above the industry average and extending its record of consistent dividend growth. An interesting angle is how this richer dividend profile, coupled with projections for stronger earnings this fiscal year, may influence how investors view the bank’s income and growth mix. We’ll now explore how First BanCorp’s enhanced dividend growth story could reshape its existing investment...